TGM2 and Crouzon syndrome-acanthosis nigricans syndrome: Thus our model provides valuable insight into the inhibition of TG2 by using new pharmacological agents to slow the progression of CAN and the application of urinary ε(γ-glutamyl)-lysine as a useful tool for monitoring CAN.